Scholars

Manganiello, Vincent C., M.D., Ph.D.

Senior Investigator

Positions:

Senior Investigator, Laboratory of Biochemical Physiology

Research Areas:

General & Internal Medicine, Endocrinology & Metabolism, Science & Technology - Other Topics, Biochemistry & Molecular Biology, Dentistry, Oral Surgery & Medicine, Cardiovascular System & Cardiology, Biophysics, Pharmacology & Pharmacy, Respiratory System, Cell Biology, Hematology, Biotechnology & Applied Microbiology, Urology & Nephrology, Immunology

Co-author Network

Map of Science

Research Areas:

overview

Vincent Manganiello earned his Ph.D. and M.D. from Johns Hopkins University in 1965 and 1967, respectively. He joined the NHLBI after his internship from 1967 to 1968 at the Harriet Lane Pediatric Service at Johns Hopkins Hospital. In 2010 he became a Senior Investigator and Chief of the Laboratory of Biochemical Physiology (CPB). A member of the NHLBI institutional review board, he also serves on the editorial boards of the Journal of Biological Chemistry and CHEST. Dr. Manganiello received the NIH Public Health Service Special Recognition Award in 1991, the NIH Director's Award in 1994, a NIH Bench to Bedside Award in 2003, and the Excellence in Sarcoidosis Research Award at the 2005 American Thoracic Society Meeting. He was admitted into the Johns Hopkins University Society of Scholars in 2012. He has authored or coauthored more than 220 papers and book chapters. He is also a member of the American Society of Molecular and Biological Chemists, American Thoracic Society, American Diabetes Association, and American College of Chest Physicians.

selected publications

Academic Articles215

(2019). Phosphodiesterase type 3A (PDE3A), but not type 3B (PDE3B), contributes to the adverse cardiac remodeling induced by pressure overload. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. 132, 60-70.
(2018). A pathophysiological role of PDE3 in allergic airway inflammation. JCI Insight. 3(2),
(2017). Phosphodiesterase 3A: a new player in development of interstitial cells of Cajal and a prospective target in gastrointestinal stromal tumors (GIST). 8(25), 41026-41043.
(2017). SFPQ, a multifunctional nuclear protein, regulates the transcription of PDE3A. BIOSCIENCE REPORTS. 37,
(2017). White to beige conversion in PDE3B KO adipose tissue through activation of AMPK signaling and mitochondrial function. Scientific Reports. 7,
(2016). Effects of heterologous expression of human cyclic nucleotide phosphodiesterase 3A (hPDE3A) on redox regulation in yeast. BIOCHEMICAL JOURNAL. 473, 4205-4225.
(2016). Modulation of Polycystic Kidney Disease Severity by Phosphodiesterase 1 and 3 Subfamilies. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 27(5), 1312-1320.
(2016). Phosphodiesterase 3B (PDE3B) regulates NLRP3 inflammasome in adipose tissue. Scientific Reports. 6,
(2015). Cyclic Nucleotide Phosphodiesterases: important signaling modulators and therapeutic targets. ORAL DISEASES. 21(1), E25-E50.
(2015). Heme Oxygenase-1 Regulation of Matrix Metalloproteinase-1 Expression Underlies Distinct Disease Profiles in Tuberculosis. JOURNAL OF IMMUNOLOGY. 195(6), 2763-2773.
(2015). Inactivation of NF-kappa B p65 (RelA) in Liver Improves Insulin Sensitivity and Inhibits cAMP/PKA Pathway. DIABETES. 64(10), 3355-3362.
(2015). Regulation of Sarcoplasmic Reticulum Ca2+ ATPase 2 (SERCA2) Activity by Phosphodiesterase 3A (PDE3A) in Human Myocardium PHOSPHORYLATION-DEPENDENT INTERACTION OF PDE3A1 WITH SERCA2. JOURNAL OF BIOLOGICAL CHEMISTRY. 290(11), 6763-6776.
(2015). Serum Apolipoprotein A-I and Large High-Density Lipoprotein Particles Are Positively Correlated with FEV1 in Atopic Asthma. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 191(9), 990-1000.
(2015). Targeted disruption of PDE3B, but not PDE3A, protects murine heart from ischemia/reperfusion injury. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 112(17), E2253-E2262.
(2015). The Role of PDE3B Phosphorylation in the Inhibition of Lipolysis by Insulin. MOLECULAR AND CELLULAR BIOLOGY. 35(16), 2752-2760.
(2015). Tuberous Sclerosis Complex 2 Loss of Heterozygosity in Patients with Lung Disease and Cancer. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 191(3), 352-355.
(2014). Advances in targeting cyclic nucleotide phosphodiesterases. NATURE REVIEWS DRUG DISCOVERY. 13(4), 290-314.
(2014). Clinical and Molecular Genetics of the Phosphodiesterases (PDEs). ENDOCRINE REVIEWS. 35(2), 195-233.
(2014). Role of phosphodiesterase 2 in growth and invasion of human malignant melanoma cells. CELLULAR SIGNALLING. 26(9), 1807-1817.
(2013). A Role for Phosphodiesterase 3B in Acquisition of Brown Fat Characteristics by White Adipose Tissue in Male Mice. ENDOCRINOLOGY. 154(9), 3152-3167.
(2013). Phosphodiesterase Type 3A Regulates Basal Myocardial Contractility Through Interacting With Sarcoplasmic Reticulum Calcium ATPase Type 2a Signaling Complexes in Mouse Heart. CIRCULATION RESEARCH. 112(2), 289-+.
(2013). Selective regulation of cyclic nucleotide phosphodiesterase PDE3A isoforms. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 110(49), 19778-19783.
(2012). Cyclic Nucleotide Phosphodiesterase 3 Signaling Complexes. HORMONE AND METABOLIC RESEARCH. 44(10), 776-785.
(2012). Regulation of the pro-inflammatory cytokine osteopontin by GIP in adipocytes - A role for the transcription factor NFAT and phosphodiesterase 3B. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 425(4), 812-817.
(2012). Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases. CELL. 148(3), 421-433.

Research Areas:

Co-author Network

Map of Science

Research Areas:

Clarivate VIVO Sandbox

Academic Articles215